Company Registry

Exopolymer Inc
Profile last edited on: 10/15/2021

Next generation biopolymer ingredients for healthcare, food, personal care, and energy markets
Year Founded
2018
First SBIR Year
2020
Latest SBIR Award
2020
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

737 Industrial Road
San Carlos, CA 94070
   (650) 799-6665
   N/A
   www.exopolymer.com
Multiple Locations:   
Congressional District:   14
County:   San Mate

Public Profile

ExoPolymer is a biotechnology company applying modern strain engineering, synthetic biology, and fermentation to produce a completely novel and highly upgraded portfolio of biopolymer products. The firm is structured around production of an entirely new and substantially upgraded portfolio of biopolymer ingredients, or hydrocolloids, for the food, healthcare, personal care, and energy markets. Exopolymers patent-pending technology involves the development of a robust, safe, and economical biological platform for the production of proprietary target molecules that are substantially improved over currently available products. It has been decades since many of today's in-use polymers with - since then - minimal upgrade: performance limitations and variability. Today's Consumer is more concerned re. ingredients in food, healthcare, and personal care products - a concern that leads ExoPolymer to address the design and manufacture of next-generation, custom biopolymers providing superior value and consistency across all forms of exopolymer usage.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
---
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Derek Wells -- Founder and CEO

  Reed Goodwin -- Director of Molecular Biology

  Sharon Long -- Founder and Chair, SAB

SBIR firms in the news

There are no news available.